๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› New Delhi
Clinical trial register · India

Clinical Trials in New Delhi

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Institute of Liver and Biliary Sciences, India46 AstraZeneca38 Novartis Pharmaceuticals22 Bristol-Myers Squibb18 Eli Lilly and Company17
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
332 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370Heart Failure
Boehringer Ingelheim
Phase 3
4,200
Aurangabad, Bangalore, Bikaner, Chennai, Kochi, Kolkata, Nashik, New Delhi
2025-05-20
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891Moderately to Severely Active Crohns Disease
Hoffmann-La Roche
Phase 3
425
Kurnool, Rajkot, Surat, Kochi, Nagpur (urban), New Delhi, Jaipur, Gachibowli
2025-05-12
Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285Myelodysplastic Syndromes
Takeda
Phase 3
225
Ahmedabad, Ernฤkulam, Mumbai, New Delhi, Ludhiana, Vellore, Ghaziabad, Kolkata
2025-05-06
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
NCT06948422Hypertension
Eli Lilly and Company
Phase 3
974
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
NCT06948435Hypertension, Overweight or Obesity
Eli Lilly and Company
Phase 3
487
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530Hypertension
Eli Lilly and Company
Phase 3
487
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc.
Phase 3
630
Visakhapatnam, Ahmedabad, Thiruvananthapuram, Mumbai, New Delhi, Bhubaneswar, Madurai, Hyderabad
2025-04-24
Recruiting
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
NCT07270809Chronic Liver Disease
Institute of Liver and Biliary Sciences, India
Observational
100
New Delhi
2025-04-15
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
New Delhi, Trivandrum, Madurai
2025-04-11
Recruiting
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
NCT06909188Biliary Tract Cancer
Institute of Liver and Biliary Sciences, India
Observational
250
New Delhi
2025-03-31
Active, closed
Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)
NCT06997367Tuberculosis (TB)
Bharat Biotech International Limited
Phase 2
164
Delhi, New Delhi
2025-03-27
Active, closed
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
NCT06726265Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Immutep S.A.S.
Phase 3
756
Bangalore, Bhubaneswar, Chennai, Kolkata, New Delhi, Thane, Thiruvananthapuram, Varanasi
2025-03-21
Recruiting
Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy
NCT06831565Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India
Not applicable
790
New Delhi
2025-03-19
Recruiting
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878Moderately to Severely Active Crohns Disease
Hoffmann-La Roche
Phase 3
600
Kurnool, Rajkot, Surat, Kochi, Nagpur (urban), New Delhi, Jaipur, Gachibowli
2025-03-17
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies
NCT06906445Ulcerative Colitis
All India Institute of Medical Sciences
Not applicable
220
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease
NCT06890650Crohn Disease
All India Institute of Medical Sciences
Not applicable
168
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis
NCT06895252Ulcerative Colitis (UC)
All India Institute of Medical Sciences
Not applicable
220
Kochi, Mumbai, New Delhi, Ludhiana, Chandigarh, Varanasi
2025-03-15
Recruiting
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies
NCT06890637Crohns Disease
All India Institute of Medical Sciences
Not applicable
168
Kochi, Mumbai, New Delhi, Ludhiana, Varanasi, Chandigarh
2025-03-15
Not yet open
Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.
NCT06855667Autoimmune Hepatitis
Institute of Liver and Biliary Sciences, India
Not applicable
50
New Delhi
2025-03-03
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
AstraZeneca
Phase 3
5,000
Bangalore, Belagavi, Hyderabad, Kolkata, Madurai, Mumbai, New Delhi, Pune
2025-03-03
Recruiting
Effects of Advanced Trauma Life Supportยฎ on Adult Trauma Patient Outcomes
NCT06321419Wounds and Injuries
Karolinska Institutet
Not applicable
4,320
Dibrugarh, Mumbai, New Delhi, Ludhiana, Dehradun, Kolkata, Chandigarh
2025-02-27
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
NCT06646276Extensive-Stage Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 3
530
Bengaluru, New Delhi, Madurai, Varanasi, Kolkata
2025-02-25
Active, closed
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naรฏve Participants With Active Psoriatic Arthritis
NCT06878404Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
552
Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi, Noida
2025-02-21
Not yet open
Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices
NCT06836778Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India
Not applicable
100
New Delhi
2025-02-20
Recruiting
Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
NCT06831643Acute Liver Failure
Institute of Liver and Biliary Sciences, India
Not applicable
40
New Delhi
2025-02-17
Rows per page Showing 101–125 of 332
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/new-delhi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.